ANGIZAAR

This brand name is authorized in Nigeria. It is also authorized in Singapore.

Active ingredients

The drug ANGIZAAR contains one active pharmaceutical ingredient (API):

1	Losartan UNII 3ST302B24A - LOSARTAN POTASSIUM
	Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
	Read more about Losartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-4214	Tablet	Angizaar-25 Tablets TAB 25 mg 3 x 10's (in Alu-Alu blisters)	Film-coated tablet. Reddish pink colored, circular, biconvex film coated tablets with MICRO engraved on one side and breakline on other side. Breakline is to facilitate breaking for ease of swallowing and not for dividing into equal doses	25/02/2021
A4-4215	Tablet	Angizaar-50 Tablets TAB 50 mg 3 x 10's (in Alu-Alu blisters)	Film-coated tablet. Bluish green coloured, circular, biconvex film-coated tablets with MICRO engraved on one side and breakline on other side. Breakline is to facilitate breaking for ease of swallowing and not for dividing into equal doses	25/02/2021
B4-5009	Tablet	Angizaar 100 Tablets TAB 100 mg 3 x 10's (in Alu-Alu blisters)	Film-coated tablet	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA01	Losartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-4214, A4-4215, B4-5009
SG	Health Sciences Authority	13720P